ArticleTranslational cancer research2024

The safety and efficacy of anti-PD-1 inhibitor-based combinational therapy in non-small cell lung cancer patients with oncogenic alterations.

Lu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.